Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report

So far, ovarian cancer has still been the most lethal gynecological malignancy. The chemotherapy and targeted medication are the mainstay for the recurrent ovarian cancer treatment. About 70% of the advanced-stage cases will relapse. Ascites-derived organoid is a pre-clinical model for the precise p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wanyi, Fang, Po-Han, Zheng, Bin, Liang, Yue, Mao, Yiwen, Jiang, Xuefeng, Tang, Qionglan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351532/
https://www.ncbi.nlm.nih.gov/pubmed/37465723
http://dx.doi.org/10.2147/IJWH.S405010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351532/
https://www.ncbi.nlm.nih.gov/pubmed/37465723
http://dx.doi.org/10.2147/IJWH.S405010

Ejemplares similares